117 related articles for article (PubMed ID: 6190592)
1. Enhancement by interferon of membrane HLA antigens in patients with combined immunodeficiency with defective HLA expression.
Durandy A; Virelizier JL; Griscelli C
Clin Exp Immunol; 1983 Apr; 52(1):173-8. PubMed ID: 6190592
[TBL] [Abstract][Full Text] [Related]
2. Alpha-interferon induces enhanced expression of HLA-ABC antigens and beta-2-microglobulin in vivo and in vitro in various subsets of human lymphoid cells.
Nissen MH; Larsen JK; Plesner T; Olesen BK; Ernst P
Clin Exp Immunol; 1987 Sep; 69(3):632-8. PubMed ID: 2959413
[TBL] [Abstract][Full Text] [Related]
3. Enhanced expression in vivo of HLA-ABC antigens and beta 2-microglobulin on human lymphoid cells induced by human interferon-alpha in patients with lung cancer. Enhanced expression of class I major histocompatibility antigens prior to treatment.
Nissen MH; Plesner T; Larsen JK; Olesen BK; Ernst P
Clin Exp Immunol; 1985 Feb; 59(2):327-35. PubMed ID: 2983911
[TBL] [Abstract][Full Text] [Related]
4. A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndrome.
Lisowska-Grospierre B; Charron DJ; de Préval C; Durandy A; Griscelli C; Mach B
J Clin Invest; 1985 Jul; 76(1):381-5. PubMed ID: 3860509
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of recombinant human leukocyte interferons on cell surface antigen expression.
Greiner JW; Fisher PB; Pestka S; Schlom J
Cancer Res; 1986 Oct; 46(10):4984-90. PubMed ID: 2944575
[TBL] [Abstract][Full Text] [Related]
6. Modulation by recombinant DNA leukocyte (alpha) and fibroblast (beta) interferons of the expression and shedding of HLA- and tumor-associated antigens by human melanoma cells.
Giacomini P; Aguzzi A; Pestka S; Fisher PB; Ferrone S
J Immunol; 1984 Sep; 133(3):1649-55. PubMed ID: 6747299
[TBL] [Abstract][Full Text] [Related]
7. Limitation of differential expression of HLA-A,B,C antigens on choriocarcinoma cell lines by messenger RNA for HLA heavy chain but not by beta 2-microglobulin.
Kawata M; Sizer K; Sekiya S; Parnes JR; Herzenberg LA
Cancer Res; 1984 Sep; 44(9):4011-6. PubMed ID: 6204750
[TBL] [Abstract][Full Text] [Related]
8. Combined immunodeficiency with defective expression of HLA: modulation of an abnormal HLA synthesis and functional studies.
Lisowska-Grospierre B; Durandy A; Virelizier JL; Fischer A; Griscelli C
Birth Defects Orig Artic Ser; 1983; 19(3):87-91. PubMed ID: 6197113
[No Abstract] [Full Text] [Related]
9. Enhanced expression of HLA antigens and beta 2-microglobulin on interferon-treated human lymphoid cells.
Fellous M; Kamoun M; Gresser I; Bono R
Eur J Immunol; 1979 Jun; 9(6):446-9. PubMed ID: 91516
[TBL] [Abstract][Full Text] [Related]
10. [Effect of interferon on human cell lines which do not express class I transplantation antigens: K 562 and Daudi. Presence of a pseudo-messenger RNA of beta 2-microglobulin in Daudi cell line].
Rosa F; Fellous M
C R Seances Acad Sci III; 1982 Oct; 295(5):359-64. PubMed ID: 6185189
[TBL] [Abstract][Full Text] [Related]
11. Chimerism and tolerance to host and donor in severe combined immunodeficiencies transplanted with fetal liver stem cells.
Bacchetta R; Vandekerckhove BA; Touraine JL; Bigler M; Martino S; Gebuhrer L; de Vries JE; Spits H; Roncarolo MG
J Clin Invest; 1993 Mar; 91(3):1067-78. PubMed ID: 8450037
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepatitis C.
Ballardini G; Groff P; Pontisso P; Giostra F; Francesconi R; Lenzi M; Zauli D; Alberti A; Bianchi FB
J Clin Invest; 1995 May; 95(5):2067-75. PubMed ID: 7738174
[TBL] [Abstract][Full Text] [Related]
13. Differential effects of human interferon alpha and interferon gamma on xenografted human thyroid tissue in severe combined immunodeficient mice and nude mice.
Kawai K; Enomoto T; Fornasier V; Resetkova E; Volpé R
Proc Assoc Am Physicians; 1997 Mar; 109(2):126-35. PubMed ID: 9069581
[TBL] [Abstract][Full Text] [Related]
14. Corticosteroids decrease the expression of beta 2-microglobulin and histocompatibility antigens on human peripheral blood lymphocytes in vitro.
Hokland M; Larsen B; Heron I; Plesner T
Clin Exp Immunol; 1981 May; 44(2):239-46. PubMed ID: 6171368
[TBL] [Abstract][Full Text] [Related]
15. Rapid turnover of HLA proteins in quiescent lymphocytes: proposed connection with immunologic surveillance.
Monos DS; Cooper HL
J Immunol; 1983 Jul; 131(1):341-6. PubMed ID: 6345664
[TBL] [Abstract][Full Text] [Related]
16. Defective expression of mononuclear cell membrane HLA antigens associated with combined immunodeficiency: impaired cellular interactions.
Zegers BJ; Heijnen CJ; Roord JJ; Kuis W; Schuurman RK; Stoop JW; Ballieux RE
Birth Defects Orig Artic Ser; 1983; 19(3):93-6. PubMed ID: 6228275
[No Abstract] [Full Text] [Related]
17. Cloned human interferon-gamma, but not interferon-beta or -alpha, induces expression of HLA-DR determinants by fetal monocytes and myeloid leukemic cell lines.
Kelley VE; Fiers W; Strom TB
J Immunol; 1984 Jan; 132(1):240-5. PubMed ID: 6418799
[TBL] [Abstract][Full Text] [Related]
18. [Effects of beta interferon on histocompatibility antigen expression in various human cell lines].
Ameglio F; Dolei A; Capobianchi MR; Palladino P; Tosi R
Ann Ist Super Sanita; 1982; 18(3):413-6. PubMed ID: 6765077
[No Abstract] [Full Text] [Related]
19. Recombinant interferon-gamma increases HLA-DR synthesis and expression.
Basham TY; Merigan TC
J Immunol; 1983 Apr; 130(4):1492-4. PubMed ID: 6403609
[TBL] [Abstract][Full Text] [Related]
20. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.
Faber LM; van Luxemburg-Heijs SA; Rijnbeek M; Willemze R; Falkenburg JH
Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
